← All stories
Health, Longevity & Biohacking

Peter Attia says BPC-157’s origin story is “unusually murky”

By Egleze Editorial Desk · Published August 10, 2026 · Peter Attia Drive · 403 ‒ Peptides: separating scientific promise from marketing hype
Peter Attia says BPC-157’s origin story is “unusually murky”
Peter Attia Drive
Peter Attia Drive
403 ‒ Peptides: separating scientific promise from marketing hype

What was said

"BPC 157 is described as a fragment of naturally occurring gastric body protection compound. But its origin story is uh unusually murky. The alleged parent protein has never been fully characterized."

Peter Attia argues BPC-157’s basic provenance is unclear, saying the supposed parent protein has not been fully characterised and that the peptide does not clearly match known human gastrointestinal peptides. He says key details such as the full sequence and original screening method appear to have been deliberately withheld, warranting scepticism about its plausibility.

Verification status

Attributed speaker claim

Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.

Source and context

Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.

Programme
Peter Attia Drive
Episode
403 ‒ Peptides: separating scientific promise from marketing hype
Clip time
13:14
Original source
Watch the source segment →
From this episode
Peter Attia Drive
Peter Attia Drive

403 ‒ Peptides: separating scientific promise from marketing hype

August 10, 2026 · 50m · 3 Egleze moments
Read episode summary and key points →

More moments from this episode

Health, Longevity & BiohackingPeter Attia says BPC-157 still lacks published peer-reviewed human RCTs→Health, Longevity & BiohackingPeter Attia says BPC-157 has patents despite “natural peptides” argument→
More stories More from Peter Attia Drive